Dr. Remington Nevin


Dr. Remington Nevin is a Vermont-based physician epidemiologist and expert consultant in the adverse effects of antimalarial drugs, particularly mefloquine (previously marketed in the United States as Lariam®). Dr. Nevin is board certified in Occupational Medicine and Public Health and General Preventive Medicine by the American Board of Preventive Medicine and Certified in Public Health by the National Board of Public Health Examiners.

A former U.S. Army Major and Preventive Medicine Officer with extensive travel medicine and policy experience, Dr. Nevin serves as Executive Director of The Quinism Foundation, a non-profit dedicated to promoting and supporting research and education on quinism, the family of medical disorders caused by poisoning by mefloquine, tafenoquine, and related quinoline drugs.

Dr. Nevin’s work has been instrumental in improving policymakers’ understanding of the potential for long-lasting and permanent neurologic and psychiatric effects from quinoline antimalarials, as exemplified by the recent FDA “black box” warning for mefloquine, and the U.S. Army Special Forces’ ban on its use among elite combat troops. Dr. Nevin has testified before the U.S. Senate, the U.K. Parliament, and the Canadian Parliament, and has provided evidence to the Irish Department of Defence on the drug’s lasting neurologic and psychiatric adverse effects confounding the diagnosis and management of posttraumatic stress disorder and traumatic brain injury. Dr. Nevin has also advocated for improvements to Peace Corps mefloquine policy to better protect the health of civilian volunteers at risk of exposure to the drug.

Dr. Nevin was first to publish clinical descriptions of the permanent toxic syndrome of brain and brainstem dysfunction caused by the use of mefloquine, including limbic encephalopathy and neurotoxic vestibulopathy, and has collaborated on the first review of the drug’s adverse effects published in the forensic psychiatry literature, and the first case report of a U.S. military veteran awarded service-related disability compensation for long-lasting adverse psychiatric effects from the drug.

Dr. Nevin is available for plaintiff and defense medicolegal consultation and has successfully aided attorney clients in the U.S., Canada, Australia, New Zealand, and the European Union in reaching favorable settlements in cases involving claims of central nervous system injury and other adverse effects from antimalarial drugs. A current fee schedule is available. Dr. Nevin is also pleased to offer his services in preparing nexus letters for veterans seeking disability compensation for injuries and illnesses arising from antimalarial exposure during military service.